Elongation factor G (EF G), bound to ribosomes either with GMPPCP or with fusidic acid and GDP, inhibits elongation factor Tu (EF Tu)-dependent binding of Phe-tRNA on the ribosome-poly(U) complex and binding of Ala-tRNA on the initiation complex formed with RNA from bacteriophage R17; GTP hydrolysis associated with Phe-tRNA binding is also inhibited. Moreover, nonenzymic binding of Phe-tRNA at high Mg++ concentration is completely blocked by EF G. Thus, EF G appears to bind at a site that overlaps or interacts with the ribosomal A-site.
Studies on the interaction of elongation factor G (EF G) with the ribosome have shown that there is a binding site for this factor (the G-site) on the 50S subunit (1, 2) . The G-site is located in a position distinct from the peptidyl-transferase center (2) and it is inactivated by the peptide antibiotics siomycin and thiostrepton, which bind to the 50S subunit and prevent the attachment of EF G (2) (3) (4) (5) (6) (7) (8) . Recent work by Tanaka and ourselves (9, 10) has shown that siomycin or thiostrepton treatment of ribosomes impairs not only their binding of EF G, but also their binding of aminoacyl-tRNA (enzymic or nonenzymic) and the elongation factor Tu (EF Tu)-dependent hydrolysis of GTP. Since these effects appear to be the consequence of a single action of the antibiotics on the 50S subunit (10) , a relationship between the binding site of EF G (the G-site) and that of the aminoacyltRNA EF Tu GTP complex (which includes the ribosomal A-site) has been suggested (9, 10) .
We have now found that with ribosomes of Escherichia coli bound EF G, stabilized either by GMPPCP (11) (12) (13) or by fusidic acid plus GDP (1, 12, [14] [15] [16] , acts much like siomycin or thiostrepton treatment in its effects on either enzymic or nonenzymic binding of aminoacyl-tRNA, and on the EF Tudependent hydrolysis of GTP. EF G can thus block the ribosomal A-site, a finding that reinforces the earlier suggestion that the G-site may be located near enough to influence, or may even overlap with, the portion of the A-site on the 50S ribosomal surface.
MATERIALS AND METHODS
Ribosomes (washed with 1 M NH4Cl), EF G, EF T (EF Ts + EF Tu), and crude initiation factors were prepared (17) (18) (19) (10) .
Poly(U), EF G, and Phe-tRNA were bound to 70S ribosomes in three consecutive incubations. Poly(U) (60-110 ,g/ml) was first incubated at 300 for 10 min with 33-38 A260 unit/ml of ribosomes in the presence of Tris * HCl (pH 7.8), Mg(acetate)2, NH4Cl, and dithiothreitol, at concentrations about twice those in the reaction mixture for the binding of Phe-tRNA (specified in the legends). The mixture was chilled and EF G was added, together with either GMPPCP or fusidic acid plus GDP or GTP. Incubation was at 300 for 3 min (with GMPPCP), or at 0°for 5 or 10 min (with fusidic acid plus GDP or GTP).
To assay nonenzymic binding of Phe-tRNA to these treated ribosomes, the reaction mixture (20 ,il) Initiation complex was formed by incubation at 340 for 10 min of 33 A260 units/ml of 70S ribosomes with 1.2 mg/ml of R17 RNA, 0.4 mg/ml of crude initiation factors, 0.4 mM GTP, and Concentrations of NH4Cl and Tris* HCl were low in the reaction mixtures (about 20 and 10 mM, respectively), since at higher concentrations these salts impair the stability of the EF G GDP ribosome-fusidic acid complex (ref. 14, and our observations).
Ribosomes and elongation factors were stored in buffer 15 pg/ml of poly(U), 20 p&M GMPPCP, 0.22 uM [y-'2P]GTP (500 cpm/pmol), 18 pmol of [14C]Phe-tRNA per A26o unit of 708 ribosomes, and, when present, 70 ug/ml of EF T and 200 ug/ml of EF G. After incubation at 00 for 2 min, the reaction mixtures were analyzed for Phe-tRNA bound and GTP hydrolyzed, as described in Methods. containing 50% glycerol. Consequently, 3-4% glycerol was present in the reaction mixtures for the binding of aminoacyltRNA.
RNA from phage R17 was prepared as described (17 (Fig. 1) , even with as much as 200 ,g/ml of EF G in the reaction mixture (see Fig. 2 To rule out the possibility that the effects observed above might be peculiar to the poly(U) system, we studied the effect of EF G on the binding of Ala-tRNA to initiation complexes formed with phage R17 RNA as messenger (23) . In this system, most Ala-tRNA binds to the A-site of ribosomes carrying fMet-tRNA (10). Table 1 (Fig. 2) . As reported by other authors (24) , this effect might be due to the low concentration of NH4+ and Tris HCl in the reaction mixtures.
A similar experiment, but with EF G bound with GMPPCP instead of fusidic acid, is shown in Table 2 . To minimize -the possibility of exchange between free and bound [y-'2PIGTP and GMPPCP, the concentration of GMPPtP was lowered 10 times compared with Fig. 1 , and ['y-82P]GTP was only in a 50% molar excess over Phe-tRNA. It is seen that EF G strongly inhibited both the binding of Phe-tRNA and its associated GTP hydrolysis. In the absence of EF G (not shown), GMPPCP did not inhibit binding or GTPase activity.
Inhibition of nonenzymic binding of Phe-tRNA In the absence of EF T (ahd GTP), efficient binding of Phe-tRNA to ribosomes complexed with poly(U) requires high Mg++ concentrations (21) . (11) (12) (13) (14) (15) (16) , strongly inhibits (60-80%) EF Tudependent binding of anminoacyl-tRNA to the ribosomal A-site, including both Phe-tRNA on the ribosomal complex with poly(U) and Ala-tRNA on the initiation complex formed with R17 RNA. Since the same effect was observed with an EF G ribosome complex stabilized by two inhibitors that act very differently, the effect is evidently due to the EF G and not to the inhibitor complexed to the ribosome in the presence of EF G. Moreover, with either inhibitor the GTPase activity associated with the enzymic binding of Phe-tRNA is also inhibited, and to a similar extent; hence, EF G can apparently prevent all detectable interaction between the GTP EF Tu aminoacyl-tRNA complex and the ribosome. The residual interaction observed might be due either to ribosomes unable to firmly bind EF G, or to a displacement of EF G from ribosomes by the GTP -EF Tu' aminoacyl-tRNA complex.
Nonenzymic binding of Phe-tRNA at 20 mM Mg++, which also takes place mainly in the ribosomal A-site (25) , is even more sensitive to inhibition by bound EF G (Table 3) .
Thus, the binding of EF G on the 50S subunit (1, 2) evidently blocks any binding of aminoacyl-tRNA, a finding that suggests that the binding site of this factor (the G-site) and that of aminoacyl-tRNA (the A-site) overlap on the 50S ribosomal surface. Alternatively, EF Proximity or overlapping of G-and A-sites was first inferred from the inhibition by siomycin and thiostrepton of both aminoacyl-tRNA and EF G binding to ribosomes (9, 10) . Moreover, our earlier suggestion that a common region on the 50S subunit may activate the GTPase of both EF G and EF Tu (10) is now made more plausible by the demonstrated inhibition of the EF Tu-dependent GTPase by El? G (Fig. 2, Table 2 ). Overlapping or interaction of G-and A-sites might also make obligatory, as first suggested by Moldave (27) , the release of EF G (or at least a "pushing aside" of this factor) after translocation, before binding of the GTP-EF Tu aminoacyl-tRNA complex can take place, and also make obligatory the release of EF Tu before binding of EF G.
Inhibition of aminoacyl-tRNA binding was equally observed when the ribosome-EF G complex was formed with either GMPPCP or fusidic acid plus GDP. Thus, GTP hydrolysis does not seem to induce a drastic change in the interaction between EF G and the A-site.
Fusidic acid, hitherto considered an inhibitor only of translocation (28, 29) , clearly can also inhibit aminoacyltRNA binding by stabilizing EF G on the ribosome and blocking the A-site. Moreover, the latter action may be more relevant to its inhibitory action on protein synthesis, and may explain the unexpected finding that polysomes inhibited by fusidic acid in vitro carry their peptidyl-tRNA in the puromycin-reactive position (30, 31) , and the finding that in protoplasts inhibited by fusidic acid, puromycin can release, albeit incompletely, nascent peptidyl chains from the ribosomes (32) .
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